The FPPAG Selection Committee has chosen the 2019 Class of Fellows in the Pediatric Pharmacy Advocacy Group. Congratulations to Leslie Briars, Gilbert Burckart, Jeffrey Cies, Lisa Lubsch, Sarah Lucas, Rachel Meyers, Kimberly Novak, and Mary Worthington.
Leslie A. Briars, PharmD, FPPAG, is a pediatric ambulatory care clinical pharmacist at the University of Illinois Hospital & Health Science System’s Child & Youth Center. She has an appointment to the College of Pharmacy as a Clinical Associate Professor. She received her Pharm.D. degree from the University of Wisconsin in Madison in 1993 and then completed a 1-year pharmacy practice residency (PGY1) in Jacksonville, FL in 1994 at the University Medical Center and University of Florida Health Science Center. In 1995, Leslie completed a 1-year pediatric pharmacy specialty residency (PGY2) at Children’s Hospital in Columbus, OH. Her areas of interest include attention deficit disorder, adolescent medicine, nephrology and HIV. Leslie has chaired the 2008 Annual Meeting and the 2017 Fall Meeting. She served on the PPAG Board of Directors from 2009 to 2012. She has also been a member and chaired the Ambulatory Care Special Interest Group.
Gilbert Burckart, PharmD, FPPAG is presently Associate Director for Pediatrics, Office of Clinical Pharmacology, U.S. Food and Drug Administration. Dr. Burckart received his B.S. in Pharmacy from the University of Pittsburgh in 1972, his Pharm.D. from the University of Kentucky in 1975, and did his pediatric residency at the UK Medical Center in Lexington and Norton Children’s Hospital in Louisville. He served on the faculties of the State University of New York at Buffalo at Buffalo Children’s Hospital, and the University of Tennessee at LeBonheur Children’s Hospital. He joined the University of Pittsburgh and the Pittsburgh Children’s Hospital in 1982 where his research focused on drug therapy in organ transplant patients. He has been Principal Investigator on NIH grants in both liver and lung transplantation. At Pitt, he was a Professor of Pharmacy, Pediatrics and Surgery, and served as Director of Research for the Division of Cardiothoracic Surgery. In 2003, he moved to the University of Southern California in Los Angeles, where he was Chairman of the Department of Pharmacy, Director of the Clinical Pharmacogenomics Laboratory, Professor of Pharmacy and Professor of Pediatrics. Dr. Burckart was an investigator at the Children’s Hospital of Los Angeles. Dr. Burckart has previously served as the President of the American College of Clinical Pharmacy, and as President of the American College of Clinical Pharmacology. He is a member of the Pediatric Pharmacy Advocacy Group, and received their Sumner J. Yaffe Lifetime Achievement Award in Pediatric Pharmacology and Therapeutics in 2014. Dr. Burckart moved to the US FDA in 2008. His duties include the direction of the Pediatric Clinical Pharmacology program within the Office of Clinical Pharmacology, and participation in the FDA’s Pediatric Review Committee. His present research program includes analyses of pediatric drug development studies from 1997 to present. He is currently Associate Editor of the Journal of Pediatric Pharmacology and Therapeutics, the official journal of PPAG.
Jeffrey Cies, PharmD, FPPAG is a pediatric clinical pharmacy specialist with over 13 years of experience in pediatric pharmacotherapy, pharmacology, pharmacometrics, and pharmacokinetics. Dr. Cies received a Bachelor of Science Degree in chemistry from Virginia Tech, a Doctor of Pharmacy degree from Virginia Commonwealth University, and a Master’s in Public Health with a concentration in bio-statistics and epidemiology from Temple University. He is the Pharmacy Clinical Coordinator at St. Christopher’s Hospital for Children in Philadelphia, PA in addition to being the pediatric ICU and Infectious Diseases clinical pharmacy specialist. Jeffrey holds adjunct faculty positions at Temple University School of Pharmacy and Drexel University College of Medicine. He has authored ~40 peer reviewed publications, has given over 80 abstract presentations at National and International meetings, and has also served as a peer reviewer for 10 different pediatric and adult medical and pharmacy journals. Dr. Cies currently holds fellowship status in the American College of Clinical Pharmacy and the American College of Critical Care Medicine. Dr. Cies served as the Chair of the 2012 and 2013 PPAG Annual Meetings, and served on the Board of Directors from 2015 to 2018. In 2015 he was awarded the Spirit of PPAG Award for his contributions as Chair of the Education Committee in 2013-2014.
Lisa Lubsch, PharmD, BCPPS, FPPAG is a Clinical Professor in the Department of Pharmacy Practice at the Southern Illinois University Edwardsville School of Pharmacy and Clinical Pharmacy Specialist at SSM Health Cardinal Glennon Children’s Hospital in St. Louis. She provides care to children with cystic fibrosis and other pulmonary problems. Dr. Lubsch received the B.S. and Doctorate of Pharmacy from the St. Louis College of Pharmacy and completed a pediatric specialty residency at the Texas Tech University Health Sciences Center School of Pharmacy. Dr. Lubsch has served PPAG is many ways. She has chaired the following Committees and Task Forces: Silent Auction Committee, 2010 Annual Meeting Committee, Education Committee and BCPPS Review Course Task Force. She served on the PPAG Board of Directors and held the positions or Secretary and President of PPAG.
Sarah Scarpace Lucas, Pharm.D. BCPS, BCPPS, FPPAG is a Pediatric Clinical Pharmacist and Senior Pharmacist Supervisor for Clinical Services at UCSF Benioff Children’s Hospital/UCSF Medical Center. She earned her BS Pharmacy and Doctor of Pharmacy degrees from University of Wisconsin-Madison and completed a Pediatric Specialty Residency at St. Louis Children’s Hospital. Dr. Lucas is an Associate Clinical Professor at UCSF School of Pharmacy and teaches didactically along with precepting students, PGY1, and PGY2 residents. As a supervisor, she oversees the clinical pharmacy services, the team-based clinical pharmacists as well as managing clinical initiatives and pharmacy-related quality and safety improvement projects. She is the director of the ASHP-accredited PGY2 Pediatric Specialty Residency program for 2 residents annually. She has 15+ years of experience as a clinical pharmacist in Heme/Onc and Critical Care practice settings and most recently pharmacy administration. Her research and practice interests include Pediatric Critical Care, Medication Safety, and Management. Dr. Lucas served as PPAG education Chair of the Education Committee, Home Program Education Committee, and the BCPPS Recertification Committee. She served on the PPAG Board from 2014-2016.
Rachel Meyers, PharmD, FPPAG is a Clinical Associate Professor at the Ernest Mario School of Pharmacy at Rutgers University, and the Pediatric Clinical Pharmacist at Saint Barnabas Medical Center in Livingston, New Jersey. Dr. Meyers completed her undergraduate degree in Biology at the University of Mary Washington and her Doctor of Pharmacy degree at the University of Connecticut. After graduation she completed a PGY-1 residency at the University of Wisconsin Hospital and Clinics in Madison, Wisconsin, and a PGY-2 residency in Pediatric Pharmacotherapy at the University of North Carolina Children’s Hospital in Chapel Hill, North Carolina. In her current position, Dr. Meyers is a clinical-track faculty who provides both didactic and experiential education in pediatric pharmacotherapy for pharmacy students and residents. Her didactic teaching covers several pediatric topics such as fluids and electrolytes, acute otitis media, pediatric hypertension, pediatric pneumonia, sickle cell anemia, and several lectures in the pediatric elective, focusing on pediatric critical care topics. In addition, she is the coordinator for the Sterile Compounding course, which is a required course for second year pharmacy students. Dr. Meyers practices in the Pediatric Intensive Care Unit and General Pediatric Unit at Saint Barnabas Medical Center. She has contributed to multiple health-system initiatives for RWJBarnabas Health, including standardizing pediatric concentrations, authoring order sets, and serving on system-wide committees including the Pediatric Sepsis committee and the Electronic Health Record (EHR) committee. Her research interests include pediatric critical care, infectious diseases, and dosage forms for children, and she has authored 15 peer-reviewed publications. Dr. Meyers has been active in many pharmacy organizations, and has been a member of PPAG since she was a student. She has served as chair of the Advocacy Committee and is the current chair of Legislative Affairs. In addition Dr. Meyers served as a representative of PPAG for the ASHP-PPAG Guidelines for providing pediatric pharmacy services in hospitals and health systems.
Kimberly Novak, PharmD, BCPS, BCPPS, FPPAG is the Advanced Patient Care Pharmacist in Pediatric and Adult Cystic Fibrosis at Nationwide Children’s Hospital in Columbus, Ohio. She has been the residency program director for the PGY2 pediatric pharmacy residency since 2006 and has trained 23 PGY2 pediatric pharmacy residents during her tenure. She also serves as a preceptor for residents in the PGY1 Pharmacy Residency and PGY1/PGY2 Health-system Pharmacy Administration Residency programs as well as visiting residents from programs in Ohio, West Virginia, and Kentucky. She has an adjunct appointment as Clinical Assistant Professor at The Ohio State University College of Pharmacy and regularly teaches in the Pediatrics Elective and Integrated Pharmacotherapy courses in addition to precepting students. Dr. Novak completed her Doctor of Pharmacy at West Virginia University in 2002 and then continued her training at University of Kentucky for her Pharmacy Practice Residency, Pediatric Specialty Residency, and Teaching Certificate. Kim has been active in PPAG since 2003 through committee involvement, publication in JPPT, presentation of both posters and lectures at annual meetings, and presentation of BCPPS preparation and recertification material at the Board Preparation and Recertification Course and via webinar. She additionally served three 1-year terms as Secretary of PPAG from 2015 to 2018. She is currently serving as President for the Ohio Society of Health- System Pharmacists. Her practice and research interests include cystic fibrosis, pharmacokinetics, antimicrobial optimization, mental health, and mentorship of pharmacy residents and students.
Mary Worthington, PharmD, BCPS, BCPPS, FPPAG is a Professor of Pharmacy Practice at the Samford University McWhorter School of Pharmacy and practices as a clinical pharmacist at Children’s of Alabama in Birmingham. She is a graduate of The Ohio State University with degrees of Bachelor of Science in Pharmacy and Doctor of Pharmacy. She completed a Residency in Hospital Pharmacy at Columbus Children’s Hospital and a Residency in Pediatric Pharmacotherapy and Home Health Care at The University of Tennessee in Memphis. Dr. Worthington has been actively involved as a pediatric pharmacy practitioner for 31 years. Her current patient care activities are primarily in the area of General Pediatrics. She is passionate about learning new and betters ways to teach pediatric pharmacy. Research interests and areas of publication include pediatric infectious diseases, pharmacy/simulation education, asthma and cerebral palsy. Dr. Worthington has been a member of the PPAG: Pediatric Pharmacy Association since 1997. She has provided service to the organization through work on the Communication/Membership, 2009 International Symposium Planning and Nominations Committees. She was a member of the Board of Directions from 2013 to 2016, and she has recently joined the faculty of PPAG University.